BridgeMD
New treatment option for Long COVID
Official title Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
ClinicalTrials.gov ID: NCT06614309
What this study is testing
- What it's testing
- This study aims to assess the effects of both acute and chronic exposures to hypoxia and hypercapnia in patients with Long COVID syndrome.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- English speaking
- Diagnosis of Long COVID
You likely can't join if
- Any history of:
- Coronary artery dissection or aortic dissection
- Neurological disease (e.g. dementia, Alzheimer's disease, or other brain-related disease)
- Cerebrovascular disease or stroke
- Aneurysm
- If currently has:
See the full eligibility criteria
- English speaking
- Diagnosis of Long COVID
- Any history of:
- Coronary artery dissection or aortic dissection
- Neurological disease (e.g. dementia, Alzheimer's disease, or other brain-related disease)
- Cerebrovascular disease or stroke
- Aneurysm
- If currently has:
- Moderate-severe chronic obstructive pulmonary disease
- Uncontrolled moderate-severe asthma
- Moderate-severe bronchiectasis
- Moderate-severe interstitial lung disease, requiring the use of supplemental oxygen
- A necessity to use supplemental oxygen, for any reason
- New or worsening symptoms (decompensation) of heart failure
- Right heart disease due to chronic pulmonary disease/sleep apnea
- Uncontrolled myocardial ischemia or angina
- Uncontrolled heart arrhythmias
- Heart or lung infection (e.g. myocarditis or pericarditis)
- Left main coronary artery stenosis
- Moderate-severe aortic stenosis
- Pulmonary embolism, pulmonary infarction, or other blood clots
- Severe respiratory disease
- Chronic kidney disease
- Chronic liver disease
- Females of childbearing potential will complete a urine pregnancy test at their baseline visit to rule out pregnancy
- BMI \>40
- Study staff unable to obtain adequate signal for cerebral blood flow
The study team makes the final eligibility decision.
Where it's taking place
- Scottsdale, Arizona, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Scottsdale, Arizona, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.